• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-145 过表达抑制神经母细胞瘤肿瘤发生和.

MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis and .

机构信息

Department of Pediatric Surgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Urology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

出版信息

Bioengineered. 2020 Dec;11(1):219-228. doi: 10.1080/21655979.2020.1729928.

DOI:10.1080/21655979.2020.1729928
PMID:32083506
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7039631/
Abstract

Neuroblastoma (NB) is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates remain poor in high-risk disease (25-40%). It is well known that miR-145 functions as a tumor suppressor in several types of cancer. However, the impact of miR-145 on NB is still ambiguous. Our aim was to investigate the potential tumor suppressive role and mechanisms of miR-145 in high-risk neuroblastoma. Expression levels of miR-145 in tissues and cells were determined using RT-qPCR. The effect of miR-145 on cell viability was evaluated using MTT assays, apoptosis levels were determined using TUNEL staining, and the MTDH protein expression was determined using western blot and RT-PCR. Luciferase reporter plasmids were constructed to confirm direct targeting for MTDH. that miR-145 expression was significantly lower in high-risk MYCN amplified (MNA) tumors and low miR-145 expression was associated with worse EFS and OS in our cohort. Over-expression of miR-145 reduced cell viability and increased apoptosis in SH-SY-5Y cells. We identified MTDH as a direct target for miR-145 in SH-SY-5Y cells. Targeting MTDH has the similar results as miR-145 overexpression. Our findings suggest that low miR-145 expression was associated with poor prognosis in patients with NB, and the overexpression of miR-145 inhibited NB cells growth by down-regulating MTDH, thus providing a potential target for the development of microRNA-based approach for NB therapy.

摘要

神经母细胞瘤(NB)是导致所有儿童癌症死亡的 15%。尽管在治疗和疾病管理方面取得了进展,但高危疾病(25-40%)的总体 5 年生存率仍然较差。众所周知,miR-145 在几种类型的癌症中起肿瘤抑制作用。然而,miR-145 对 NB 的影响仍然不清楚。我们的目的是研究 miR-145 在高危神经母细胞瘤中的潜在肿瘤抑制作用和机制。使用 RT-qPCR 确定组织和细胞中 miR-145 的表达水平。使用 MTT 测定法评估 miR-145 对细胞活力的影响,使用 TUNEL 染色测定细胞凋亡水平,使用 Western blot 和 RT-PCR 测定 MTDH 蛋白表达。构建荧光素酶报告质粒以确认对 MTDH 的直接靶向作用。发现高危 MYCN 扩增(MNA)肿瘤中 miR-145 的表达明显降低,我们的队列中低 miR-145 表达与 EFS 和 OS 较差相关。miR-145 的过表达降低了 SH-SY-5Y 细胞的活力并增加了细胞凋亡。我们确定 MTDH 是 SH-SY-5Y 细胞中 miR-145 的直接靶标。靶向 MTDH 具有与 miR-145 过表达相似的结果。我们的研究结果表明,NB 患者中低 miR-145 表达与预后不良相关,miR-145 的过表达通过下调 MTDH 抑制 NB 细胞生长,从而为 miRNA 为基础的 NB 治疗方法的开发提供了潜在的靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/e97c78d7f442/kbie-11-01-1729928-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/1b861ceaf8d7/kbie-11-01-1729928-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/a36f9b8cf80a/kbie-11-01-1729928-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/b87790e15d8e/kbie-11-01-1729928-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/ce49ce09a944/kbie-11-01-1729928-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/e97c78d7f442/kbie-11-01-1729928-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/1b861ceaf8d7/kbie-11-01-1729928-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/a36f9b8cf80a/kbie-11-01-1729928-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/b87790e15d8e/kbie-11-01-1729928-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/ce49ce09a944/kbie-11-01-1729928-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2323/7039631/e97c78d7f442/kbie-11-01-1729928-g005.jpg

相似文献

1
MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis and .miR-145 过表达抑制神经母细胞瘤肿瘤发生和.
Bioengineered. 2020 Dec;11(1):219-228. doi: 10.1080/21655979.2020.1729928.
2
MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.MicroRNA-497 通过靶向关键细胞周期调节因子 WEE1 增加 MYCN 扩增神经母细胞瘤细胞的凋亡。
Mol Cancer. 2013 Mar 26;12:23. doi: 10.1186/1476-4598-12-23.
3
MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.微小RNA-149与人类神经母细胞瘤的临床预后相关,并通过不依赖MYCN扩增的Rap1调节癌细胞增殖。
Biochimie. 2017 Aug;139:1-8. doi: 10.1016/j.biochi.2017.04.011. Epub 2017 Apr 27.
4
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.miR-15a-5p、miR-15b-5p 和 miR-16-5p 通过直接靶向神经母细胞瘤中的 MYCN 抑制肿瘤进展。
Mol Oncol. 2020 Jan;14(1):180-196. doi: 10.1002/1878-0261.12588. Epub 2019 Nov 29.
5
[Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].[微小RNA-144通过靶向MYCN对小儿神经母细胞瘤增殖、凋亡和顺铂耐药的影响]
Zhonghua Zhong Liu Za Zhi. 2019 Jul 23;41(7):516-521. doi: 10.3760/cma.j.issn.0253-3766.2019.07.006.
6
MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.微小RNA-497通过靶向细胞周期、存活及血管通透性基因来抑制化疗耐药性神经母细胞瘤细胞的生长。
Oncotarget. 2016 Feb 23;7(8):9271-87. doi: 10.18632/oncotarget.7005.
7
MicroRNA-1247 inhibits cell proliferation by directly targeting ZNF346 in childhood neuroblastoma.微小 RNA-1247 通过直接靶向神经母细胞瘤中的 ZNF346 抑制细胞增殖。
Biol Res. 2018 May 24;51(1):13. doi: 10.1186/s40659-018-0162-y.
8
SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.SNHG16 通过海绵吸附 miR-128-3p 下调 HOXA7 抑制神经母细胞瘤进展。
Neurochem Res. 2020 Apr;45(4):825-836. doi: 10.1007/s11064-020-02955-x. Epub 2020 Jan 9.
9
miR-200a inhibits tumor proliferation by targeting AP-2γ in neuroblastoma cells.微小RNA-200a通过靶向神经母细胞瘤细胞中的AP-2γ抑制肿瘤增殖。
Asian Pac J Cancer Prev. 2014;15(11):4671-6. doi: 10.7314/apjcp.2014.15.11.4671.
10
Histone deacetylase HDAC2 regulates microRNA-125a expression in neuroblastoma.组蛋白去乙酰化酶 HDAC2 调控神经母细胞瘤中 microRNA-125a 的表达。
Brain Behav. 2022 Feb;12(2):e2401. doi: 10.1002/brb3.2401. Epub 2022 Jan 21.

引用本文的文献

1
Epigenetic Dysregulation in -Amplified Neuroblastoma.- 扩增神经母细胞瘤中的表观遗传学失调。
Int J Mol Sci. 2023 Dec 3;24(23):17085. doi: 10.3390/ijms242317085.
2
Crosstalk Between miRNA and Protein Expression Profiles in Nitrate-Exposed Brain Cells.硝酸盐暴露的脑细胞中 miRNA 和蛋白质表达谱的串扰。
Mol Neurobiol. 2023 Jul;60(7):3855-3872. doi: 10.1007/s12035-023-03316-9. Epub 2023 Mar 27.
3
Peptide Targeted Gold Nanoplatform Carrying miR-145 Induces Antitumoral Effects in Ovarian Cancer Cells.携带miR-145的肽靶向金纳米平台在卵巢癌细胞中诱导抗肿瘤作用。

本文引用的文献

1
MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.miR-132 通过靶向 TGF-β1 抑制顺铂耐药口腔鳞状细胞癌细胞的迁移和侵袭并增加其化疗敏感性。
Bioengineered. 2020 Dec;11(1):91-102. doi: 10.1080/21655979.2019.1710925.
2
MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution.微小RNA在神经母细胞瘤的肿瘤发生、治疗抗性及疾病进展中的作用
Cancer Drug Resist. 2019;2(4):1086-1105. doi: 10.20517/cdr.2019.68. Epub 2019 Dec 19.
3
MicroRNA-145 Inhibits Cell Migration and Invasion in Colorectal Cancer by Targeting TWIST.
Pharmaceutics. 2022 Apr 28;14(5):958. doi: 10.3390/pharmaceutics14050958.
4
Methyltransferase-like 3 induces the development of cervical cancer by enhancing insulin-like growth factor 2 mRNA-binding proteins 3-mediated apoptotic chromatin condensation inducer 1 mRNA stability.甲基转移酶样蛋白 3 通过增强胰岛素样生长因子 2 mRNA 结合蛋白 3 介导的凋亡染色质凝聚诱导因子 1 mRNA 的稳定性诱导宫颈癌的发展。
Bioengineered. 2022 Mar;13(3):7034-7048. doi: 10.1080/21655979.2022.2044261.
5
Astragalus polysaccharide (APS) exerts protective effect against acute ischemic stroke (AIS) through enhancing M2 micoglia polarization by regulating adenosine triphosphate (ATP)/ purinergic receptor (P2X7R) axis.黄芪多糖(APS)通过调节三磷酸腺苷(ATP)/嘌呤能受体(P2X7R)轴增强 M2 小胶质细胞极化,发挥对急性缺血性脑卒中(AIS)的保护作用。
Bioengineered. 2022 Feb;13(2):4468-4480. doi: 10.1080/21655979.2021.1980176.
6
Long noncoding RNA H19 suppresses cardiac hypertrophy through the MicroRNA-145-3p/SMAD4 axis.长链非编码 RNA H19 通过 MicroRNA-145-3p/SMAD4 轴抑制心肌肥厚。
Bioengineered. 2022 Feb;13(2):3826-3839. doi: 10.1080/21655979.2021.2017564.
7
Long intergenic non-protein coding RNA 1273 confers sorafenib resistance in hepatocellular carcinoma via regulation of methyltransferase 3.长链非编码 RNA 1273 通过调控甲基转移酶 3 赋予肝癌索拉非尼耐药性。
Bioengineered. 2022 Feb;13(2):3108-3121. doi: 10.1080/21655979.2022.2025701.
8
Deciphering the Role of MicroRNAs in Neuroblastoma.解析 microRNAs 在神经母细胞瘤中的作用。
Molecules. 2021 Dec 24;27(1):99. doi: 10.3390/molecules27010099.
9
Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2.miR-21-5p 抑制剂与 Aurora 激酶抑制剂协同治疗通过靶向芽生 RTK 信号拮抗剂 2 抑制乳腺癌进展。
Bioengineered. 2022 Jan;13(1):455-468. doi: 10.1080/21655979.2021.2009410.
10
MYCN in Neuroblastoma: "Old Wine into New Wineskins".神经母细胞瘤中的MYCN:“旧瓶装新酒”
Diseases. 2021 Oct 29;9(4):78. doi: 10.3390/diseases9040078.
微小RNA-145通过靶向TWIST抑制结直肠癌细胞的迁移和侵袭。
Onco Targets Ther. 2019 Dec 10;12:10799-10809. doi: 10.2147/OTT.S216147. eCollection 2019.
4
MiR-145: a potential biomarker of cancer migration and invasion.微小RNA-145:癌症迁移和侵袭的潜在生物标志物。
Am J Transl Res. 2019 Nov 15;11(11):6739-6753. eCollection 2019.
5
Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p.长链非编码 RNA MIR17HG 通过 miR-17-5p 促进结直肠癌的进展。
Cancer Res. 2019 Oct 1;79(19):4882-4895. doi: 10.1158/0008-5472.CAN-18-3880. Epub 2019 Aug 13.
6
Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis.塞来昔布通过 miRNA-145/TGFBR2/Smad3 轴抑制膀胱癌中的上皮间质转化。
Int J Mol Med. 2019 Aug;44(2):683-693. doi: 10.3892/ijmm.2019.4241. Epub 2019 Jun 12.
7
Dysregulated microRNAs in colorectal carcinogenesis: New insight to cell survival and apoptosis regulation.结直肠癌发生过程中失调的 microRNAs:对细胞存活和凋亡调控的新认识。
J Cell Physiol. 2019 Dec;234(12):21683-21693. doi: 10.1002/jcp.28872. Epub 2019 May 26.
8
The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells.miR-145-5p 或 miR-145-3p 通过靶向 MTDH 与前列腺癌患者的预后相关,并调节前列腺癌细胞的生长和转移。
Int J Oncol. 2019 Jun;54(6):1955-1968. doi: 10.3892/ijo.2019.4782. Epub 2019 Apr 12.
9
miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.组织中 miR-145 的表达水平可预测食管鳞癌患者的预后。
Pathol Res Pract. 2019 Jun;215(6):152401. doi: 10.1016/j.prp.2019.03.029. Epub 2019 Mar 27.
10
Advances in Anti-GD2 Immunotherapy for Treatment of High-risk Neuroblastoma.用于治疗高危神经母细胞瘤的抗GD2免疫疗法的进展
J Pediatr Hematol Oncol. 2019 Apr;41(3):163-169. doi: 10.1097/MPH.0000000000001369.